Article Information
History
- November 27, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan
- 2Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, US Department of Health and Human Services, Fort Collins, Colorado, USA
- ↵*Correspondence: Day-Yu Chao, Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, 145 Xingda Rd., Taichung 402, Taiwan, Tel: 886-4-22840694, E-mail: dychao{at}nchu.edu.tw or Gwong-Jen J. Chang, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, 3156 Rampart Rd., Fort Collins, CO 80521, USA, Tel: 970-221-6497, E-mail: gxc7{at}cdc.gov
Posted November 27, 2018.
Cross-reactivity reduced dengue virus serotype 2 vaccine does not confer cross-protection against other serotypes of dengue viruses
